期刊文献+

富血小板纤维蛋白促进组织愈合机制的探讨 被引量:18

The mechanism of tissue healing promoted by platelet-rich fibrin
在线阅读 下载PDF
导出
摘要 目的:通过检测富血小板纤维蛋白(platelet-rich fibrin,PRF)中多种细胞因子的表达,探讨其在组织再生修复中的作用。方法:取健康志愿者肘静脉全血制备PRF标本,通过免疫组化的实验方法,检测标本中IL-1β、IL-4、IL-6、TNF、PDGF-BB和TGF-β1的表达。结果:免疫组化结果表明富血小板纤维蛋白标本中IL-1β、IL-4、IL-6、TNF、PDGF-BB和TGF-β1均为阳性表达。结论:富血小板纤维蛋白中含有多种细胞因子,这些细胞因子与纤维蛋白共同发挥作用使PRF具有减少术后反应、降低术后感染风险和促进组织愈合的作用。 Objective:We detected the expression of cytokines in platelet-rich fibrin(PRF) to explore its effect on tissue healing.Method: Cubital vein blood of healthy volunteers was taken to make samples of PRF.We detected the expression of IL-1β,IL-4,IL-6,TNF-α,PDGF-BB and TGF-β1 in PRF through immunohistochemistry.Results: The results of immunohistochemistry showed that the expressions of IL-1β,IL-4,IL-6,TNF-α,PDGF-BB and TGF-β1 in PRF were all positive.Conclusion: Biology trials showed that platelet-rich fibrin expressed various cytokines,these cytokines together with fibrin play the role in reducing postoperative reaction,reducing the risk of postoperative infection and promoting tissue healing.
出处 《中国口腔种植学杂志》 2011年第4期198-200,共3页 Chinese Journal of Oral Implantology
关键词 富血小板纤维蛋白 组织愈合 生长因子 免疫因子 platelet-rich fibrin tissue healing growth factors immune factors
作者简介 通讯作者:张剑明。邮箱地址:zjming17@163.com
  • 相关文献

参考文献11

  • 1David M,Joseph C,Antoine D,et al.Platelet-rich fibrin (PRF):A second-generation platelet concentrate.Part Ⅰ:Technological concepts and evolution[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006,101:E37-44.
  • 2Joseph C,Antoine D,Alain S,et al.Platelet-rich fibrin (PRF):A second-generation platelet concentrate.Part Ⅳ:Clinical effects on tissue healing[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006,101:E56-60.
  • 3Marx RE,Carlson ER,Eichstaedt RM,Schimmele SR,Strauss JE,Georgeff KR.Platelet-rich plasma:growth factor enhancement for bone grafts.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-46.
  • 4Antonaides HN.Human platelet derived growth factor (PDGF):purification of PDGF-Ⅰ and PDGF-Ⅱ and separation of their reduced sub-units [J].Proc Natl Acad Sci USA,1981,78:7314-7317.
  • 5Ogino Y,Ayukawa Y,Kukita T,Koyano K.he contribution of platelet-derived growth factor,transforming growth factor-betal,and insulin-like growth factor-Ⅰ in platelet-rich plasma to the proliferation of osteoblast-like cells[J].Oral Surg Oral Med Oral Pathol Oral Radiol,2006,101 (6):724-729.
  • 6Dohan Ehrenfest DM,Diss A,Odin G,et al.In vitro effects of Choukroun's PRF (platelet-rich fibrin)on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2009,108(3):341-352.
  • 7Loike JD,Sodeik B,Cao L,Leucona S,Weitz JI,Detmers PA,et al.CD11c/CD18 on neutrophils recognizes a domain at theN terminus of the A alpha chain of fibrinogen.Proc Natl AcadSci U S A 1991;88:1044-8.
  • 8Lundquist R,Dziegiel MH,Agren MS.Bioactivity and stability of endogenous fibrogenic factors in platelet-rich fibrin[J] Wound Repair Regen,2008,16 (3):356-363.
  • 9丁桂凤.白细胞介素1的生物活性[J].国外医学:免疫学分册,1987,10(2):57-61.
  • 10高久史磨 赵德荣.白细胞介素.国际免疫学杂志,1987,:201-204.

二级参考文献21

  • 1Idriss HT,Naismith JH.TNF alpha and the TNF receptor superfamily:structure-function relationship[J].Micros Res 2000,50(3):184-195.
  • 2Barone D,Krantz C,Lambert D,et al.Comparative analysis of the ability of etanercept and infliximab to lyse TNE-expressing cells in a complement dependent fashion [J].Arthritis Rheum 1999,42:S369-375.
  • 3Peppel K,Crawford D,Beutler B,et al.A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity[J].J Exp Med 1991,174:1483-1489.
  • 4AderkaD,Engelmann H,Shemer-AvniI,et al.Variation in serum levels of the soluble TNF receptors among healthy individuals[J].Lymphokine Cytokine Res 1992,10:157-159.
  • 5Woley PH,Dutcher J,Widmer MB,et al.Influence of a recombinant human soluble tumor necrosis factor Fc fusion protein on type Ⅱ collagen-induced arthritis in mice[J].J Immunol 1993,151:6602 -6607.
  • 6Garrison L.McDonnell N D.Etanercept:therapeutic use in patients with rheumatoid arthritis[J].Ann Rheum Dis 1999,58(Suppl Ⅰ):165-169.
  • 7Lovell D J.Etanercept in children with polyarticular juvenile rheumatoid arthritis[J].New Engl J Med 2000,340:253-259.
  • 8Alldred A.Etanercept in rheumatoid arthritis[J].Expert Opin Pharmacother 2001,2(7):1137-1148.
  • 9ZeltserR,Valle L,Tanck c,et al.Clinical,histological,and immunophenotypic characteristics of injection site reactions associated with etanercept:a recombinant tumor necrosis factor alpha receptor:Fc fusion protein[J].Arch Dermatol 2001,137(7):893-899.
  • 10BaroneD,Krantz C,Lambert D,et al.Comparative analysis of the ability of etanercept and infliximab to lyse TNF-expressing cells in a complement dependent fashion [J].Arthritis Rheum 1999,42:S369-375.

共引文献12

同被引文献208

引证文献18

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部